Nicotinic receptor activation increases [3H]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex

scientific article published on 16 December 2008

Nicotinic receptor activation increases [3H]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1124/JPET.108.147025
P932PMC publication ID2682260
P698PubMed publication ID19088301
P5875ResearchGate publication ID23669207

P2093author name stringJun Zhu
Linda P Dwoskin
Subbu Apparsundaram
P2860cites workNicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal CortexQ44620915
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.Q44904935
Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortexQ44985022
Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine releaseQ45200225
Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structureQ46399860
Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortexQ46526741
Nicotine increases dopamine clearance in medial prefrontal cortex in rats raised in an enriched environmentQ46937479
In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.Q48257541
Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neuronsQ48428303
Blockade of nicotine self-administration with nicotinic antagonists in rats.Q52177843
Nicotine effects on dopamine clearance in rat nucleus accumbens.Q52204067
Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.Q52290825
Effects of subchronic nicotine administration on central dopaminergic mechanisms in the ratQ69372796
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptakeQ72432303
Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp studyQ27867696
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse linesQ28215161
Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytesQ28301363
Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nucleiQ28564628
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatumQ28585149
Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortexQ34284808
Monoamine transporters: from genes to behaviorQ34931139
Neuropharmacology of paroxetineQ35562763
Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanismQ35893691
Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation.Q35925910
Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulationQ36052826
The dopamine transporter proteomeQ36458668
Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimerasQ36807852
Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.Q40474520
Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions.Q40528317
Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.Q40603141
Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparationsQ40634379
Cocaine increases dopamine uptake and cell surface expression of dopamine transportersQ40753544
The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomesQ41884930
Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortexQ42491932
Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatumQ42522412
Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinityQ43510598
The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.Q43788914
Responses to cholinergic agonists of rats selectively bred for differential sensitivity to ethanolQ43829310
N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slicesQ44453355
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectdopamineQ170304
P304page(s)931-939
P577publication date2008-12-16
P1433published inJournal of Pharmacology and Experimental TherapeuticsQ1500272
P1476titleNicotinic receptor activation increases [3H]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex
P478volume328

Reverse relations

cites work (P2860)
Q37701053Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
Q33808035Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.
Q36350809Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner
Q34709290Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.
Q38446589Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure.
Q36944251HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes
Q37672037HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
Q30498578Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function
Q92927264Molecular Mechanism and Dynamics of S-Deoxyephedrine Moving through Molecular Channels within D3R
Q34132214Pharmacogenetics of nicotine addiction: role of dopamine
Q37838857The effects of nicotine and cigarette smoke on the monoamine transporters
Q42709614The effects of nicotine and tobacco particulate matter on dopamine uptake in the rat brain
Q42949791Upregulation of norepinephrine transporter function by prolonged exposure to nicotine in cultured bovine adrenal medullary cells